The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.
Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod / Rovesti, M.; Zucchi, A.; Feliciani, C.; Satolli, F.. - In: ANAIS BRASILEIROS DE DERMATOLOGIA. - ISSN 0365-0596. - 96:5(2021), pp. 565-568. [10.1016/j.abd.2020.08.025]
Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod
Zucchi A.;Feliciani C.;Satolli F.
2021-01-01
Abstract
The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.File | Dimensione | Formato | |
---|---|---|---|
brasileiros miriam.pdf
accesso aperto
Tipologia:
Versione (PDF) editoriale
Licenza:
Creative commons
Dimensione
947.96 kB
Formato
Adobe PDF
|
947.96 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.